Back to Search
MR. MICHAEL K YU MD
MD
Urology Physician
NPI: 1104816131IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
04-29272(KS)35088520(OH)
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1995
Research & Publications (20)
Treatment of chronic hepatitis C in Asia: when East meets West.
PMID 19335784·J Gastroenterol Hepatol·2009
6-review
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial.
PMID 18508296·Hepatology·2008
4-observational
Significant association of ABCG8:D19H gene polymorphism with hypercholesterolemia and insulin resistance.
PMID 18581044·J Hum Genet·2008
8-other
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C.
PMID 16956917·Gut·2007
4-observational
Long-term effects of interferon-based therapy for chronic hepatitis C.
PMID 18087178·Oncology·2007
6-review
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.
PMID 17302371·Antivir Ther·2006
3-trial
Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
PMID 16938649·Transl Res·2006
8-other
A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan.
PMID 16420512·Liver Int·2006
4-observational
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
PMID 17058238·Hepatology·2006
3-trial
A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
PMID 17105583·Liver Int·2006
8-other
A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
PMID 17302368·Antivir Ther·2006
4-observational
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study.
PMID 15823212·BMC Infect Dis·2005
2-rct
[Demonstration of simultaneous infection with dengue type 2 and 3 in a Chinese patient].
PMID 16110945·Wei Sheng Wu Xue Bao·2004
5-case
A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factors.
PMID 15196817·Antiviral Res·2004
8-other
Tumor necrosis factor alpha promoter polymorphisms at position -308 in Taiwanese chronic hepatitis C patients treated with interferon-alpha.
PMID 12834858·Antiviral Res·2003
8-other
Human leukocyte antigen class I and II alleles and response to interferon-alpha treatment, in Taiwanese patients with chronic hepatitis C virus infection.
PMID 12825172·J Infect Dis·2003
8-other
The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.
PMID 11243756·J Infect·2001
8-other
Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan.
PMID 11505444·J Med Virol·2001
8-other
GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy.
PMID 11675141·Antiviral Res·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2350 MIAMI VALLEY DR STE 500
CENTERVILLE, OH 45459 - Phone
- (937) 425-0003
Quick Facts
- NPI
- 1104816131
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile